News

Just a single odor can induce a defense response in sweet potatoes to herbivores and protects other plants against potential invaders, according to a new study.

Make-up products used every day by millions of people in the UK are contaminated with potentially deadly bugs, such as E. coli and Staphylococci, because most are not being cleaned and are used far beyond their expiry dates.

New research has discovered why gas bubbles in narrow vertical tubes appear to remain stuck – they are in fact just moving very, very slowly.

A team has identified a combination of two drugs that work to relax the walls of the ureter — and can be delivered directly to the ureter with a catheter-like instrument. Relaxing the ureter could help kidney stones clear more easily.

Researchers have introduced a new synthetic process for producing an important family of carbon-based molecules known as γ-aryl-β-ketoesters. These molecules are used in the production of many vital pharmaceuticals.

Scientists have discovered how stem cell mutations quietly arise and spread throughout a widening field of the colon until they eventually transform into a malignancy.

The U.S. spends $5 billion a year to repair damages to road infrastructure from winter snow and ice control operations and the use of traditional deicers. A team of researchers is developing a more sustainable solution using grape skins and other agricultural waste.

Materials scientists have shown that it is possible to achieve photon up-conversion, – the emission of light with energy higher than the one that excites the material. This development brings scientists a step closer to developing minimally invasive photodynamic cancer treatments,

A newly published study shows that a small molecule has the ability to induce the self-destruction of pancreatic cancer cells.

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.